# PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and Uptake Research on Eroxon)

> **NCT07636161** · PHASE4 · SUSPENDED · sponsor: **University of Miami** · enrollment: 30 (estimated)

## Conditions studied

- Type 2 Diabetes
- Type 2 Diabetes (T2DM)

## Interventions

- **DEVICE:** Eroxon®
- **DRUG:** tadalafil

## Key facts

- **NCT ID:** NCT07636161
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2026-10
- **Primary completion:** 2027-09
- **Final completion:** 2027-09
- **Target enrollment:** 30 (ESTIMATED)
- **Why stopped:** The sponsor has communicated that they may no longer fund this research study. Pending final confirmation if the study will be closed.
- **Last updated:** 2026-09-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07636161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07636161, "PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and Uptake Research on Eroxon)". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07636161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*